Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts

被引:120
作者
Felsher, DW [1 ]
Zetterberg, A
Zhu, JY
Tlsty, T
Bishop, JM
机构
[1] Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Pathol, Div Oncol, Stanford, CA 94305 USA
[3] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
[4] Canc Ctr Karolinska, Dept Oncol Pathol, Stockholm, Sweden
[5] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA
[6] GW Hooper Fdn, San Francisco, CA 94143 USA
关键词
D O I
10.1073/pnas.190327097
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Overexpression of the proto-oncogene MYC has been implicated in the genesis of diverse human cancers. One explanation for the role of MYC in tumorigenesis has been that this gene might drive cells inappropriately through the division cycle, leading to the relentless proliferation characteristic of the neoplastic phenotype. Herein, we report that the overexpression of MYC alone cannot sustain the division cycle of normal cells but instead leads to their arrest in G(2) We used an inducible form of the MYC protein to stimulate normal human and rodent fibroblasts. The stimulated cells passed through G(1) and S but arrested in G(2) and frequently became aneuploid, presumably as a result of inappropriate reinitiation of DNA synthesis. Absence of the tumor suppressor gene p53 or its downstream effector p21 reduced the frequency of both G(2) arrest and aneuploidy, apparently by compromising the G(2) checkpoint control. Thus, relaxation of the G(2) checkpoint may be an essential early event in tumorigenesis by MYC, The loss of p53 function seems to be one mechanism by which this relaxation commonly occurs. These findings dramatize how multiple genetic events can collaborate to produce neoplastic cells.
引用
收藏
页码:10544 / 10548
页数:5
相关论文
共 27 条
[1]  
BLYTH K, 1995, ONCOGENE, V10, P1717
[2]   Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].
Bunz, F ;
Dutriaux, A ;
Lengauer, C ;
Waldman, T ;
Zhou, S ;
Brown, JP ;
Sedivy, JM ;
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 282 (5393) :1497-1501
[3]  
CERNI C, 1986, CURR TOP MICROBIOL, V132, P193
[4]   MYC abrogates p53-mediated cell cycle arrest in N-(Phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification [J].
Chernova, OB ;
Chernov, MV ;
Ishizaka, Y ;
Agarwal, ML ;
Stark, GR .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (01) :536-545
[5]  
Di Leonardo A, 1997, CANCER RES, V57, P1013
[6]   Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14ARF tumor suppressor [J].
Dimri, GP ;
Itahana, K ;
Acosta, M ;
Campisi, J .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (01) :273-285
[7]   CHIMERAS OF MYC ONCOPROTEIN AND STEROID-RECEPTORS CAUSE HORMONE-DEPENDENT TRANSFORMATION OF CELLS [J].
EILERS, M ;
PICARD, D ;
YAMAMOTO, KR ;
BISHOP, JM .
NATURE, 1989, 340 (6228) :66-68
[8]   Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis [J].
Eischen, CM ;
Weber, JD ;
Roussel, MF ;
Sherr, CJ ;
Cleveland, JL .
GENES & DEVELOPMENT, 1999, 13 (20) :2658-2669
[9]   Transient excess of MYC activity can elicit genomic instability and tumorigenesis [J].
Felsher, DW ;
Bishop, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :3940-3944
[10]   Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation [J].
Greenberg, RA ;
O'Hagan, RC ;
Deng, HY ;
Xiao, QR ;
Hann, SR ;
Adams, RR ;
Lichtsteiner, S ;
Chin, L ;
Morin, GB ;
DePinho, RA .
ONCOGENE, 1999, 18 (05) :1219-1226